This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Abo Akademi. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Innovations by Fang Cheng in HPV-Induced Carcinoma Treatment
Introduction
Fang Cheng is an accomplished inventor based in Åbo, Finland. He has made significant contributions to the field of medical research, particularly in the treatment of HPV-induced carcinoma. His innovative work has led to the development of a unique compound that holds promise for improving patient outcomes.
Latest Patents
Fang Cheng holds 1 patent for his invention titled "Compounds for the treatment of HPV-induced carcinoma - A compound of Formula 1." This patent represents a crucial step forward in the fight against HPV-related cancers, showcasing his dedication to advancing medical science.
Career Highlights
Fang Cheng is affiliated with Abo Akademi, where he continues to engage in groundbreaking research. His work at the university has positioned him as a key figure in the study of cancer treatments, particularly those targeting viral-induced malignancies.
Collaborations
Fang collaborates with talented colleagues, including Senthil Kumar Rajendran and Preethy Paul, who contribute to his research efforts. Their combined expertise enhances the potential for innovative solutions in the medical field.
Conclusion
Fang Cheng's contributions to the treatment of HPV-induced carcinoma exemplify the impact of innovative research in medicine. His work not only advances scientific knowledge but also offers hope for improved therapies for patients affected by this disease.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile